End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.12 CNY | +1.90% | +1.73% | -3.64% |
10:44am | US FDA Grants Clinical Trial Approval for Fosun Unit's Gastric Cancer Tablets | MT |
04-30 | Fosun Pharma's Q1 Profit Slumps 38% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.64% | 8B | |
+32.49% | 690B | |
+26.43% | 546B | |
-4.95% | 358B | |
+18.02% | 323B | |
+5.03% | 287B | |
+14.28% | 235B | |
+5.81% | 199B | |
-9.37% | 195B | |
+4.90% | 161B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Fosun Pharma Wins Regulatory Nod for Offering of $889 Million Renminbi Bonds in China